Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
- PMID: 16682948
- DOI: 10.1038/sj.onc.1209641
Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
Abstract
The complex apoptotic functions of the p53 tumor suppressor are central to its antineoplastic activity in vivo. Besides its well-known action as a transcriptional activator of apoptotic genes, p53 exerts a direct proapoptotic role at the mitochondria via protein-protein interactions with Bcl2 family members, thus executing the shortest known circuitry of p53 death signaling. We recently reported that exclusive delivery of p53 to mitochondria exerts a significant in vivo tumor suppressor activity in p53-null lymphomas. However, it was unknown whether mitochondrially targeted p53 has suppressor activities in tumors harboring missense mutants, which constitute the vast majority of p53 alterations in human tumors. Here, we show that targeting p53 to mitochondria does confer a significant growth disadvantage in B-lymphomas expressing various point mutants of p53, resulting in efficient apoptosis induction in vitro and in vivo in mice.
Similar articles
-
Mitochondrially targeted p53 has tumor suppressor activities in vivo.Cancer Res. 2005 Nov 1;65(21):9971-81. doi: 10.1158/0008-5472.CAN-05-1084. Cancer Res. 2005. PMID: 16267022
-
p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.Oncogene. 2006 Aug 7;25(34):4725-43. doi: 10.1038/sj.onc.1209601. Oncogene. 2006. PMID: 16892086 Review.
-
p53 mutation heterogeneity in cancer.Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. doi: 10.1016/j.bbrc.2005.03.190. Biochem Biophys Res Commun. 2005. PMID: 15865939 Review.
-
Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.Oncogene. 2007 May 3;26(20):2939-44. doi: 10.1038/sj.onc.1210085. Epub 2006 Oct 30. Oncogene. 2007. PMID: 17072342
-
Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.Cancer Res. 2008 May 15;68(10):3707-14. doi: 10.1158/0008-5472.CAN-07-6776. Cancer Res. 2008. PMID: 18483253
Cited by
-
p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity.Cell Res. 2008 Jul;18(7):733-44. doi: 10.1038/cr.2008.62. Cell Res. 2008. PMID: 18504456 Free PMC article.
-
Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model.Cell Cycle. 2008 Aug 15;7(16):2584-90. doi: 10.4161/cc.7.16.6070. Epub 2008 Aug 7. Cell Cycle. 2008. PMID: 18719383 Free PMC article.
-
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.Blood. 2012 Nov 8;120(19):3986-96. doi: 10.1182/blood-2012-05-433334. Epub 2012 Sep 5. Blood. 2012. PMID: 22955915 Free PMC article.
-
A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.Genome Res. 2022 Jan;32(1):135-149. doi: 10.1101/gr.275437.121. Epub 2021 Dec 28. Genome Res. 2022. PMID: 34963661 Free PMC article.
-
Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.FEBS Lett. 2008 Apr 16;582(9):1319-24. doi: 10.1016/j.febslet.2008.03.013. Epub 2008 Mar 20. FEBS Lett. 2008. PMID: 18358838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous